Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786
Excerpt
In the original publication [...]
Share and Cite
Bednarek, A.M.; Owczarek, A.J.; Dziadosz, D.; Olszanecka-Glinianowicz, M.; Chudek, J.T. Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786. Diagnostics 2026, 16, 1040. https://doi.org/10.3390/diagnostics16071040
Bednarek AM, Owczarek AJ, Dziadosz D, Olszanecka-Glinianowicz M, Chudek JT. Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786. Diagnostics. 2026; 16(7):1040. https://doi.org/10.3390/diagnostics16071040
Chicago/Turabian StyleBednarek, Anna Maria, Aleksander Jerzy Owczarek, Dominika Dziadosz, Magdalena Olszanecka-Glinianowicz, and Jerzy Tadeusz Chudek. 2026. "Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786" Diagnostics 16, no. 7: 1040. https://doi.org/10.3390/diagnostics16071040
APA StyleBednarek, A. M., Owczarek, A. J., Dziadosz, D., Olszanecka-Glinianowicz, M., & Chudek, J. T. (2026). Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786. Diagnostics, 16(7), 1040. https://doi.org/10.3390/diagnostics16071040

